Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation
(Q34191632)
scientific article
scientific article
Language:
Current Data About
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation
other details
description | scientific article |
External Links
(P356) |
10.1023/A:1006478317173
|
(P698) |
11261828
|
(P6179) |
1025713798
|